Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome
- 31 October 1983
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 106 (4), 876-880
- https://doi.org/10.1016/0002-8703(83)90010-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathwayThe American Journal of Cardiology, 1982
- Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1982
- Effect of drugs in the wolff-parkinson-white syndrome: Importance of initial length of effective refractory period of the accessory pathwayThe American Journal of Cardiology, 1980
- Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.Heart, 1980
- Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathwayThe American Journal of Cardiology, 1980
- Atrial fibrillation in the preexcitation syndromeThe American Journal of Cardiology, 1977
- Clinical efficacy of amiodarone as an antiarrhythmic agentThe American Journal of Cardiology, 1976
- Effect of amiodarone in the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1976
- Wolff-Parkinson-White syndrome and atrial fibrillation: Relation between refractory period of accessory pathway and ventricular rate during atrial fibrillationThe American Journal of Cardiology, 1974
- Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochlorideThe American Journal of Cardiology, 1974